+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genetically Modified Experimental Animal Model Market - Global Forecast 2025-2030- Product Image
Genetically Modified Experimental Animal Model Market - Global Forecast 2025-2030- Product Image
Sale

Genetically Modified Experimental Animal Model Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6141586
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Genetically modified animal models are transforming biomedical research, offering critical platforms for disease modeling, drug validation, and translational innovation. As industry and research institutions race to leverage advanced genome editing, decision-makers need a comprehensive understanding of evolving technologies, regulatory standards, and the risks and opportunities affecting global supply chains.

Market Snapshot: Genetically Modified Animal Models

The genetically modified animal model market is characterized by sustained expansion, underpinned by the widespread adoption of CRISPR/Cas9 and related gene editing tools. Investment in both foundational research and applied biopharmaceutical pipelines drives market vitality. Steady growth across North America, Europe, and Asia-Pacific is complemented by intensifying interest from emerging markets, as regional innovation hubs and global research networks fuel demand for specialized animal model services. Market participants—including academic institutions, contract research organizations, and biotechnology companies—are increasingly focused on operational efficiency, compliance, and scientific precision.

Scope & Segmentation of Genetically Modified Animal Model Research

This report delivers a granular analysis across market sub-segments and key regional dynamics to support informed decision-making. It covers:

  • Animal Model Type: Mouse, Rat, Rabbit, Zebrafish
  • Genetic Modification Technology: CRISPR/Cas9 (including CRISPR activation, knockin, knockout), RNAi, TALENs, Zinc Finger Nucleases
  • Disease Area: Cardiovascular, Immunology, Metabolic Disorders, Neurology, Oncology
  • End User: Academic and Research Institutes, Contract Research Organizations, Hospitals and Clinical Labs, Pharmaceutical and Biotechnology Companies
  • Service Type: Genetic Screening Service, Model Generation Service, Phenotyping Service, Regulatory Compliance Service
  • Regions Covered: Americas (with focused breakdown of the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Major Companies Profiled: Charles River Laboratories International, Inc., Envigo RMS LLC, Taconic Biosciences, Inc., The Jackson Laboratory, GenOway SA, Horizon Discovery Group Ltd, Cyagen Biosciences Inc., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Crown Bioscience, Inc., Beijing Vitalstar Biotechnology Co., Ltd.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Advances in genome editing, particularly CRISPR/Cas9, are enabling rapid development of disease models aligned with evolving therapeutic targets.
  • Interdisciplinary collaboration among academic centers, contract research organizations, and industry is accelerating model validation and reducing time to clinical application.
  • Compliance with emerging global regulations and ethical standards is now integral to successful project execution and market differentiation.
  • End-user segments show distinct demand profiles: academic stakeholders seek comprehensive discovery support, while industry partners prioritize streamlined drug development workflows and regulatory guidance.
  • Regional dynamics reveal a diversification of R&D capabilities, with North America leading translational innovation, Asia-Pacific scaling high-throughput research, and EMEA fostering regulatory convergence and ethical oversight.

Tariff Impact on Supply Chain and Research Continuity

United States tariff changes effective in 2025 are creating new challenges within the animal model market. Increased duties on imported reagents and specialty equipment have compelled organizations to revise sourcing strategies, emphasizing domestic procurement and localized manufacturing. These measures are altering research timelines, cost structures, and collaborative frameworks for globally distributed teams. Entities are addressing these uncertainties by negotiating long-term supply agreements, developing modular supply infrastructures, and prioritizing cost-transparency throughout operational planning.

Methodology & Data Sources

This report is grounded in a combined approach: primary interviews with sector experts and executives, secondary research across scientific literature and public filings, and the deployment of proprietary analytical models. Systematic segmentation and triangulation were applied for accuracy and to surface actionable trends.

Why This Report Matters

  • Equips senior stakeholders with objective, actionable intelligence for technology adoption, regulatory alignment, and supply chain planning.
  • Delivers segmentation clarity to help tailor resources and partnership models across animal types, technologies, and end users.
  • Supports strategic investments by identifying new market opportunities, compliance risks, and regional innovation dynamics.

Conclusion

As genetically modified animal models enable new therapeutic pathways and operational excellence, industry leaders must integrate cutting-edge technologies, robust compliance frameworks, and agile supply strategies to maintain an adaptive, competitive position.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of CRISPR/Cas9 gene editing in transgenic rodent disease models
5.2. Development of humanized mouse models for immuno-oncology and translational research
5.3. Expansion of inducible and conditional knockout rat models for metabolic disease studies
5.4. Integration of automated phenotyping and imaging platforms for GM animal model characterization
5.5. Emergence of microbiome-modified gnotobiotic animal models to study host-microbe interactions
5.6. Ethical and regulatory frameworks evolving for xenotransplantation in genetically modified pigs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genetically Modified Experimental Animal Model Market, by Animal Model Type
8.1. Introduction
8.2. Mouse
8.3. Rabbit
8.4. Rat
8.5. Zebrafish
9. Genetically Modified Experimental Animal Model Market, by Genetic Modification Technology
9.1. Introduction
9.2. CRISPR/Cas9
9.2.1. CRISPR Activation
9.2.2. CRISPR Knockin
9.2.3. CRISPR Knockout
9.3. RNAi
9.4. TALENs
9.5. Zinc Finger Nucleases
10. Genetically Modified Experimental Animal Model Market, by Disease Area
10.1. Introduction
10.2. Cardiovascular
10.3. Immunology
10.4. Metabolic Disorders
10.5. Neurology
10.6. Oncology
11. Genetically Modified Experimental Animal Model Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Clinical Labs
11.5. Pharmaceutical And Biotechnology Companies
12. Genetically Modified Experimental Animal Model Market, by Service Type
12.1. Introduction
12.2. Genetic Screening Service
12.3. Model Generation Service
12.4. Phenotyping Service
12.5. Regulatory Compliance Service
13. Americas Genetically Modified Experimental Animal Model Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Genetically Modified Experimental Animal Model Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Genetically Modified Experimental Animal Model Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Charles River Laboratories International, Inc.
16.3.2. Envigo RMS LLC
16.3.3. Taconic Biosciences, Inc.
16.3.4. The Jackson Laboratory
16.3.5. GenOway SA
16.3.6. Horizon Discovery Group Ltd
16.3.7. Cyagen Biosciences Inc.
16.3.8. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
16.3.9. Crown Bioscience, Inc.
16.3.10. Beijing Vitalstar Biotechnology Co., Ltd.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHAI
FIGURE 26. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHSTATISTICS
FIGURE 27. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHCONTACTS
FIGURE 28. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RABBIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RABBIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ZEBRAFISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ZEBRAFISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR ACTIVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR ACTIVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR KNOCKIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR KNOCKIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR KNOCKOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR KNOCKOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RNAI, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RNAI, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TALENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TALENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY HOSPITALS AND CLINICAL LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY HOSPITALS AND CLINICAL LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC SCREENING SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC SCREENING SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL GENERATION SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL GENERATION SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PHENOTYPING SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PHENOTYPING SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGULATORY COMPLIANCE SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGULATORY COMPLIANCE SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 98. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 99. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 102. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 103. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 104. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 105. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 114. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 115. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 116. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 117. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 172. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 173. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 176. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 177. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 178. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 179. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 183. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 184. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 185. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 188. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 189. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 190. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 191. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 207. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 208. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 209. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 212. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 213. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 214. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 215. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 220. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 221. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 224. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 225. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 226. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 227. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. SPAIN GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE AREA, 2025-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC MODIFICATION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA GENETICALLY MODIFIED EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CRISPR/CAS9, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Genetically Modified Experimental Animal Model Market report include:
  • Charles River Laboratories International, Inc.
  • Envigo RMS LLC
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • GenOway SA
  • Horizon Discovery Group Ltd
  • Cyagen Biosciences Inc.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  • Crown Bioscience, Inc.
  • Beijing Vitalstar Biotechnology Co., Ltd.

Related Topics

Related Reports

Animal Model Market - Global Forecast 2025-2030 - Product Image

Animal Model Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Animal Model: Market Share, and Growth Analysis by Product Type (Transgenic Models, Knockout Models, Hybrid Models, Immunodeficient Models), Application, End User, Technology - Product Image

Animal Model: Market Share, and Growth Analysis by Product Type (Transgenic Models, Knockout Models, Hybrid Models, Immunodeficient Models), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Animal Model - Global Strategic Business Report - Product Image

Animal Model - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Experimental Animal Model Market - Global Forecast 2025-2030 - Product Image

Experimental Animal Model Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Animal Model Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Animal Model Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.